Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Más filtros

Bases de datos
País/Región como asunto
Tipo del documento
País de afiliación
Intervalo de año de publicación
1.
Neurology ; 69(6): 536-45, 2007 Aug 07.
Artículo en Inglés | MEDLINE | ID: mdl-17679672

RESUMEN

OBJECTIVE: To examine the association between caffeine intake, cognitive decline, and incident dementia in a community-based sample of subjects aged 65 years and over. METHODS: Participants were 4,197 women and 2,820 men from a population-based cohort recruited from three French cities. Cognitive performance, clinical diagnosis of dementia, and caffeine consumption were evaluated at baseline and at 2 and 4 year follow-up. RESULTS: Caffeine consumption is associated with a wide range of sociodemographic, lifestyle, and clinical variables which may also affect cognitive decline. Multivariate mixed models and multivariate adjusted logistic regression indicated that women with high rates of caffeine consumption (over three cups per day) showed less decline in verbal retrieval (OR = 0.67, CI = 0.53, 0.85), and to a lesser extent in visuospatial memory (OR = 0.82, CI = 0.65, 1.03) over 4 years than women consuming one cup or less. The protective effect of caffeine was observed to increase with age (OR = 0.73, CI = 0.53, 1.02 in the age range 65 to 74; OR = 0.3, CI = 0.14, 0.63 in the range 80+). No relation was found between caffeine intake and cognitive decline in men. Caffeine consumption did not reduce dementia risk over 4 years. CONCLUSIONS: The psychostimulant properties of caffeine appear to reduce cognitive decline in women without dementia, especially at higher ages. Although no impact is observed on dementia incidence, further studies are required to ascertain whether caffeine may nonetheless be of potential use in prolonging the period of mild cognitive impairment in women prior to a diagnosis of dementia.


Asunto(s)
Cafeína/farmacología , Café , Trastornos del Conocimiento/prevención & control , Cognición/efectos de los fármacos , Demencia/prevención & control , Fármacos Neuroprotectores/farmacología , Arteritis del Sistema Nervioso Central por SIDA , Anciano , Anciano de 80 o más Años , Agnosia/epidemiología , Agnosia/prevención & control , Péptidos beta-Amiloides/antagonistas & inhibidores , Cafeína/administración & dosificación , Trastornos del Conocimiento/epidemiología , Estudios de Cohortes , Demencia/epidemiología , Progresión de la Enfermedad , Femenino , Estudios de Seguimiento , Francia/epidemiología , Humanos , Incidencia , Masculino , Trastornos de la Memoria/epidemiología , Trastornos de la Memoria/prevención & control , Fármacos Neuroprotectores/administración & dosificación , Estudios Prospectivos , Antagonistas de Receptores Purinérgicos P1 , Factores de Riesgo , Muestreo , Caracteres Sexuales , Población Urbana/estadística & datos numéricos , Aprendizaje Verbal/efectos de los fármacos
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA